Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Comoli

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Blood|March 16, 2002
Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replicationPatrizia Comoli, Massimo Labirio, Sabrina Basso, et al.
British Journal of Haematology|October 4, 2007
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptidesAntonio Curti, Patrizia Tosi, Patrizia Comoli, et al.
Bone Marrow Transplantation|June 28, 2025
Early HHV-6 reactivation increases the risk of graft rejection after haploidentical hematopoietic cell transplantationFrancesca Compagno, Stella Boghen, Tommaso Mina, et al.
Elife|April 26, 2022
Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferationClaudio Tripodo, Barbara Bassani, Elena Jachetti, et al.
Journal of Neuroinflammation|November 7, 2020
Air pollution as a contributor to the inflammatory activity of multiple sclerosisAndrea Cortese, Luca Lova, Patrizia Comoli, et al.
Viruses|July 30, 2025
Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian CentersMaria Magdalena Pocora, Paola Bini, Giulia Berzero, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 18, 2014
DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplantAugusto Tagliamacco, Michela Cioni, Patrizia Comoli, et al.
Blood|December 17, 2009
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatmentGiovanni Riva, Mario Luppi, Patrizia Barozzi, et al.
Transplantation Direct|July 15, 2017
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort StudyErica Franceschini, Jessica Plessi, Stefano Zona, et al.
Cancers|June 22, 2023
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1<sup>mut</sup>) for the Treatment of NPM1<sup>mut</sup>-Acute Myeloid LeukemiaMarica De Cicco, Ivana Lagreca, Sabrina Basso, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Blood|March 16, 2002
Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replicationPatrizia Comoli, Massimo Labirio, Sabrina Basso, et al.
British Journal of Haematology|October 4, 2007
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptidesAntonio Curti, Patrizia Tosi, Patrizia Comoli, et al.
Bone Marrow Transplantation|June 28, 2025
Early HHV-6 reactivation increases the risk of graft rejection after haploidentical hematopoietic cell transplantationFrancesca Compagno, Stella Boghen, Tommaso Mina, et al.
Elife|April 26, 2022
Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferationClaudio Tripodo, Barbara Bassani, Elena Jachetti, et al.
Journal of Neuroinflammation|November 7, 2020
Air pollution as a contributor to the inflammatory activity of multiple sclerosisAndrea Cortese, Luca Lova, Patrizia Comoli, et al.
Viruses|July 30, 2025
Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian CentersMaria Magdalena Pocora, Paola Bini, Giulia Berzero, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 18, 2014
DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplantAugusto Tagliamacco, Michela Cioni, Patrizia Comoli, et al.
Blood|December 17, 2009
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatmentGiovanni Riva, Mario Luppi, Patrizia Barozzi, et al.
Transplantation Direct|July 15, 2017
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort StudyErica Franceschini, Jessica Plessi, Stefano Zona, et al.
Cancers|June 22, 2023
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1<sup>mut</sup>) for the Treatment of NPM1<sup>mut</sup>-Acute Myeloid LeukemiaMarica De Cicco, Ivana Lagreca, Sabrina Basso, et al.
Pageof 14